10-70772523-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001318241.2(TBATA):c.964G>A(p.Glu322Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,614,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001318241.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBATA | NM_001318241.2 | c.964G>A | p.Glu322Lys | missense_variant | 10/11 | ENST00000456372.4 | NP_001305170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBATA | ENST00000456372.4 | c.964G>A | p.Glu322Lys | missense_variant | 10/11 | 1 | NM_001318241.2 | ENSP00000400224.3 | ||
TBATA | ENST00000692183.1 | c.961G>A | p.Glu321Lys | missense_variant | 10/11 | ENSP00000509602.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251472Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135914
GnomAD4 exome AF: 0.000161 AC: 235AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.000147 AC XY: 107AN XY: 727232
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.961G>A (p.E321K) alteration is located in exon 10 (coding exon 8) of the TBATA gene. This alteration results from a G to A substitution at nucleotide position 961, causing the glutamic acid (E) at amino acid position 321 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at